Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2009-03-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.07M03780PMID 19254516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients.

  2007cited by this paper
• A Meta-Analysis of Early Sustained Response Rates Between Antidepressants and Placebo for the Treatment of Major Depressive Disorder

  2006cited by this paper
• Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.

  2006cited by this paper
• ‘Delay’ hypothesis of onset of antidepressant action

  2006cited by this paper
• Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

  2006cited by this paper
• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

  2006cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Is there a delay in the antidepressant effect? A meta-analysis.

  2005cited by this paper
• Trajectories of Treatment Response in Late-Life Depression: Psychosocial and Clinical Correlates

  2005cited by this paper
• Onset of antidepressant action: a pharmacological question?

  2005cited by this paper
• Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.

  2005cited by this paper
• Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression

  2004cited by this paper
• [Venlafaxine titration dosage in depressive in-patients. A series of cases].

  2003cited by this paper
• Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

  2003cited by this paper
• The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial

  2001cited by this paper
• Clinical Guidelines for the Treatment of Depressive Disorders IV. Medications and Other Biological Treatments

  2001cited by this paper
• Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology.

  2000cited by this paper
• Timing of onset of antidepressant response with fluoxetine treatment.

  2000cited by this paper
• Fluoxetine Versus Moclobemide: Cross-Comparison Between the Time Courses of Improvement

  1999cited by this paper
• Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines.

  1998cited by this paper
• The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.

  1998cited by this paper
• Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out‐patients with inadequate treatment response

  1997cited by this paper
• Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses.

  1996cited by this paper
• Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment?

  1996cited by this paper
• Early nonresponse to fluoxetine as a predictor of poor 8-week outcome.

  1995cited by this paper
• Further evidence that a placebo response to antidepressants can be identified.

  1993cited by this paper
• Use of pattern analysis to identify true drug response. A replication.

  1987cited by this paper
• The timing, specificity and clinical prediction of tricyclic drug effects in depression

  1987cited by this paper

• The predictive value of niacin skin flushing response and inflammatory factors for the antidepressant efficacy.

  2026cites this paper
• Predictors of the Effectiveness of Psychedelics in Treating Depression—A Scoping Review

  2026cites this paper
• A novel, experimental design to assess rapid antidepressant action: Results from a phase 1b randomized trial of NV-5138.

  2026cites this paper
• Personalised & optimised therapy (POT) algorithm using five cognitive and behavioural skills for subthreshold depression

  2025cites this paper
• Response to "Letter to the editor regarding: "Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression" by ".

  2025cites this paper
• Response prediction of antidepressants: Using graph theory tools for brain network connectivity analysis

  2025cites this paper
• Current Progress in Targeted Pharmacotherapy to Treat Symptoms of Major Depressive Disorder: Moving From Broad-Spectrum Treatments to Precision Psychiatry.

  2025cites this paper
• Antidépresseurs : aspects thérapeutiques

  2025cites this paper
• Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeks

  2025cites this paper
• Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.

  2025cites this paper
• Early Improvement Predicts Treatment Response in Depression: An Ecological Momentary Assessment Study in an Inpatient and Day Clinic Setting.

  2025cites this paper
• Comparative polygenic predispositions of treatment-resistant depression in East Asian and European populations

  2025cites this paper
• A decision-analytic method to evaluate the cost-effectiveness of remote monitoring technology for chronic depression

  2025cites this paper
• EEG microstates as indicators of major depressive disorder and predictors of response through 4 weeks of treatment in adolescents.

  2025cites this paper
• Digital phenotyping of depression: A multi-modal passive sensing approach to identifying novel behavioral and physiological markers of treatment response.

  2025cites this paper
• Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.

  2024cites this paper
• Optimizing the Prediction of Depression Remission: A Longitudinal Machine Learning Approach

  2024cites this paper
• Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression

  2024cites this paper
• Core antibiotic resistance genes mediate gut microbiota to intervene in the treatment of major depressive disorder.

  2024cites this paper
• Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression

  2024cites this paper
• When to hold and when to fold: Early prediction of nonresponse to transcranial magnetic stimulation in major depressive disorder.

  2024influential citation
• Early change in specific depression symptoms and later outcome in internet-delivered psychotherapy for depression: A cohort study and cross-lagged network analysis.

  2024cites this paper
• Early-treatment cerebral blood flow change as a predictive biomarker of antidepressant treatment response: evidence from the EMBARC clinical trial.

  2024cites this paper
• Electrophysiological predictors of early response to antidepressants in major depressive disorder.

  2024cites this paper
• Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2).

  2024cites this paper
• Genetic determinants of antidepressant and antipsychotic drug response

  2024cites this paper
• Methodological choices and clinical usefulness for machine learning predictions of outcome in Internet-based cognitive behavioural therapy

  2024cites this paper
• Early improvement with cariprazine as a predictor of antidepressant, anxiolytic, and antimanic response in bipolar I mania and depression: A pooled post hoc analysis of randomized cariprazine trials.

  2024cites this paper
• Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

  2023cites this paper
• Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial

  2023cites this paper
• Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

  2023cites this paper
• Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study

  2023cites this paper
• Early outcomes, associated factors and predictive values of clinical outcomes of tandospirone in generalized anxiety disorder: a post-hoc analysis of a randomized, controlled, multicenter clinical trial

  2023cites this paper
• Association between Plasma Metabolic Profiles of the Antidepressant Escitalopram and Clinical Response in Subjects with Depression

  2023cites this paper
• Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI

  2023cites this paper
• Different roles of microbiota and genetics in the prediction of treatment response in major depressive disorder.

  2023cites this paper
• Factors associated with early and late response to electroconvulsive therapy

  2023cites this paper
• Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedicated Control Group

  2023cites this paper
• Antidepressant treatment initiation and public sick-leave compensation in the following year: a register-based prospective cohort study in Denmark

  2023cites this paper
• Prospective study of antidepressant treatment of psychiatric patients with depressive disorders: treatment adequacy and outcomes

  2023cites this paper
• Impact of pH and membrane nature on distribution and permeability processes of nortriptyline hydrochloride

  2023cites this paper
• Effect of intermittent theta burst stimulation on suicidal ideation and depressive symptoms in adolescent depression with suicide attempt: A randomized sham-controlled study.

  2023cites this paper
• Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy

  2023cites this paper
• Decreased step count prior to the first visit for MDD treatment: a retrospective, observational, longitudinal cohort study of continuously measured walking activity obtained from smartphones

  2023cites this paper
• Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and P11 Gene DNA Methylation.

  2023cites this paper
• Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis

  2023cites this paper
• Local and large-scale resting-state oscillatory dysfunctions for early antidepressant response prediction in major depressive disorder.

  2023cites this paper
• Rethinking the medication management of major depression

  2023cites this paper
• Factors Affecting Antidepressant Response Trajectories: A Veterans Affairs Augmentation and Switching Treatments for Improving Depression Outcomes Trial Report

  2023cites this paper
• The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression

  2023cites this paper
• A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression.

  2023cites this paper
• Roxadustat (FG-4592) abated lipopolysaccharides-induced depressive-like symptoms via PI3K signaling

  2023cites this paper
• Predictive validity of the Edinburgh postnatal depression scale and other tools for screening depression in pregnant and postpartum women: a systematic review and meta-analysis

  2022cites this paper
• Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways

  2022cites this paper
• Early Improvement Predicts Clinical Outcomes Similarly in 10 Hz rTMS and iTBS Therapy for Depression

  2022cites this paper
• Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia.

  2022cites this paper
• Cortical Thickness Predicts Response Following 2 Weeks of SSRI Regimen in First-Episode, Drug-Naive Major Depressive Disorder: An MRI Study

  2022cites this paper
• Serum Mature BDNF Level Is Associated with Remission Following ECT in Treatment-Resistant Depression

  2022cites this paper
• Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial

  2022cites this paper
• Effect of the Early Administration of Selective Serotonin Reuptake Inhibitors on the Time Course of Poststroke Fatigue: A 2-Year Longitudinal Study

  2022cites this paper
• Is It Time to Try Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Again?

  2022cites this paper
• Distinct Features of Cerebral Blood Flow and Spontaneous Neural Activity as Integrated Predictors of Early Response to Antidepressants

  2022cites this paper
• Lipid Biomarkers in Depression: Does Antidepressant Therapy Have an Impact?

  2022cites this paper
• Replication of distinct trajectories of antidepressant response to intravenous ketamine.

  2022cites this paper
• Absence of early mood improvement as a robust predictor of rTMS nonresponse in major depressive disorder

  2022cites this paper
• Early Response to Antidepressant Medications in Adults With Major Depressive Disorder

  2022cites this paper
• Predicting relapse from the time to remission during the acute treatment of depression: A re-analysis of the STAR*D data.

  2022cites this paper
• Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report

  2022cites this paper
• Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report

  2022cites this paper
• The interaction of P11 methylation and early-life stress impacts the antidepressant response in patients with major depressive disorder.

  2022cites this paper
• Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis

  2022cites this paper
• Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder

  2022cites this paper
• Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study

  2022cites this paper
• The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy

  2021influential citation
• The network analysis of depressive symptoms before and after two weeks of antidepressant treatment.

  2021cites this paper
• High-frequency repetitive transcranial magnetic stimulation (rTMS) accelerates onset time of beneficial treating effects and improves clinical symptoms of depression.

  2021cites this paper
• Prediction of Clinical Outcomes With EEG Microstate in Patients With Major Depressive Disorder

  2021cites this paper
• Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder.

  2021cites this paper
• A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

  2021cites this paper
• Functional connectivity of the hippocampus in predicting early antidepressant efficacy in patients with major depressive disorder.

  2021cites this paper
• Pharmacological treatment of a depressive episode and recurrent depressive disorder - guidelines of the Polish Psychiatric Association and the National Consultant for Adult Psychiatry.

  2021cites this paper
• Individualized functional connectome identified replicable biomarkers for dysphoric symptoms in first-episode medication-naïve patients with major depressive disorder.

  2021cites this paper
• Predicting Neuroimaging Biomarkers for Antidepressant Selection in Early Treatment of Depression

  2021cites this paper
• Prevalence, median time, and associated factors with the likelihood of initial antidepressant change: a cross-sectional study in Qatar

  2021cites this paper
• Analysis of the Pharmacological Management of Major Depressive Disorder in 100 Consecutive Psychiatric Referrals from Two Family Practice Locations in Rural Canada

  2021cites this paper
• Early response to trazodone once-a-day in major depressive disorder: review of the clinical data and putative mechanism for faster onset of action

  2021cites this paper
• Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression.

  2021cites this paper
• Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan

  2021cites this paper
• Baseline Anxiety, and Early Anxiety/Depression Improvement in Anxious Depression Predicts Treatment Outcomes with Escitalopram: A CAN-BIND-1 Study Report.

  2021cites this paper
• Attenuated alpha–gamma coupling in emotional dual pathways with right‐Amygdala predicting ineffective antidepressant response

  2021cites this paper
• Setting the Stage for Major Depressive Disorder Recovery: Strategies for the Busy Primary Care Provider

  2021cites this paper
• NDT_A_340309 3735..3741

  2021cites this paper
• Predicting Treatment Selections for Individuals with Major Depressive Disorder According to Functional Connectivity Subgroups

  2021cites this paper
• Predicting trajectories of symptom change during and following treatment in adolescents with Unipolar Major Depression

  2020cites this paper
• Anhedonia in Major Depressive Disorder (MDD) is Reduced by Transcranial Magnetic Stimulation (TMS)

  2020cites this paper
• Does Treatment Response With Antidementia Drugs After 6 Months in Alzheimer's Disease Predict Long-term Treatment Outcome?

  2020cites this paper
• Annual Research Review: Defining and treating pediatric treatment-resistant depression.

  2020cites this paper
• Grant Report on SCH: Personalized Depression Treatment Supported by Mobile Sensor Analytics

  2020cites this paper
• Prevalence, Median Time and Associated Factors with the Likelihood of Initial Antidepressant Change in Treatment of Major Depressive Disorder: A Cross-Sectional Study in Qatar.

  2020cites this paper
• Using early changes in cold cognition to predict response to vortioxetine in major depressive fisorder.

  2020cites this paper